Paul Chaintreuil

Paul Chaintreuil

Auto-generated profile, based on publicly available information

Paul Chaintreuil

Université Côte d’Azur, INSERM, C3M 1 , Nice, France

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ADAnne Doye
Anne Doye
PCPaul Chaintreuil
Paul Chaintreuil
CLChantal Lagresle-Peyrou
Chantal Lagresle-Peyrou
LBLudovic Batistic
Ludovic Batistic
VMValentine Marion
Valentine Marion
Laurent BoyerLaurent Boyer
Laurent Boyer
A growing number of patients presenting severe combined immunodeficiencies attributed to monoallelic RAC2 variants have been identified. The expression of the RHO GTPase RAC2 is restricted to the hematopoietic lineage. RAC2 variants have been described to cause immunodeficiencies associated with high frequency of infection, leukopenia, and autoinflammatory features. Here, we show that specific RAC2 activating mutations induce the NLRP3 inflammasome activation leading to the secretion of IL-1β and IL-18 from macrophages. This activation depends on the activation state of the RAC2 variant and is mediated by the downstream kinase PAK1. Inhibiting the RAC2–PAK1–NLRP3 inflammasome pathway might be considered as a potential treatment for these patients.